Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lupus in adolescence.

I Kone-Paut1, M Piram, S Guillaume

  • 1Department of Pediatrics and Pediatric Rheumatology, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France. isabelle.kone-paut@bct.aphp.fr

Lupus
|August 23, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydropower reservoirs - their potential association with transmission of trematodes in Vietnam.

Journal of helminthology·2025
Same author

Unravelling the clinical heterogeneity of undefined recurrent fever over time in the European registries on Autoinflammation.

Pediatric rheumatology online journal·2024
Same author

Impact of multiple sclerosis on employment and income: Insights from a random sample representative of private sector employees in France using longitudinal administrative data.

Revue neurologique·2024
Same author

How to reduce the complication rate of multiple burr holes surgery in moyamoya angiopathy.

Acta neurochirurgica·2023
Same author

French protocol for the diagnosis and management of familial Mediterranean fever.

La Revue de medecine interne·2023
Same author

French national diagnostic and care protocol for Kawasaki disease.

La Revue de medecine interne·2023
Same journal

Association of GPX4 rs713041 and rs4807542 polymorphisms and serum GPX4 levels in Chinese patients with systemic lupus erythematosus.

Lupus·2026
Same journal

Giant cell myocarditis in an 18-year-old patient with new-onset systemic lupus erythematosus: A fatal case of rapidly progressing heart failure.

Lupus·2026
Same journal

An evidence-based specialist nursing protocol for children with hypoprothrombinemia-lupus anticoagulant syndrome (HLAS) and its application research.

Lupus·2026
Same journal

T-bet expression in B cell subsets: Association with T peripheral helper cells and clinical activity in systemic lupus erythematosus.

Lupus·2026
Same journal

Autonomic dysfunction in systemic lupus erythematosus and systemic sclerosis.

Lupus·2026
Same journal

Recent advances in the management of pediatric neuropsychiatric lupus from conventional therapies to novel immunomodulators.

Lupus·2026
See all related articles

Juvenile systemic lupus erythematosus (JSLE) often presents with vague symptoms, delaying diagnosis and leading to significant organ damage. Early detection and new therapies are improving outcomes, but long-term management remains complex.

Area of Science:

  • Pediatrics
  • Rheumatology
  • Immunology

Background:

  • Juvenile systemic lupus erythematosus (JSLE) accounts for 15-20% of all systemic lupus erythematosus (SLE) cases.
  • JSLE frequently presents with non-specific constitutional symptoms like fatigue and headache, leading to diagnostic delays.
  • High rates of irreversible organ damage, particularly renal, musculoskeletal, and neuropsychiatric, are observed in JSLE patients.

Purpose of the Study:

  • To summarize the key aspects of juvenile systemic lupus erythematosus.
  • To highlight diagnostic challenges and long-term complications.
  • To discuss current and emerging therapeutic strategies and management goals.

Main Methods:

  • Literature review of juvenile systemic lupus erythematosus.

Related Experiment Videos

  • Analysis of presenting symptoms, diagnostic delays, and organ damage.
  • Evaluation of treatment modalities and management objectives.

    • Main Results:

    • JSLE diagnosis is often delayed due to non-specific symptoms.
    • Renal, musculoskeletal, and neuropsychiatric systems are commonly affected, leading to irreversible damage.
    • While prognosis has improved, cardiovascular, hematological events, and chronic renal failure remain significant causes of mortality.

    Conclusions:

    • Effective JSLE management requires controlling disease progression, ensuring treatment adherence, and mitigating medication side effects.
    • Addressing patients' quality of life, psychosocial development, and transition to adult care are crucial.
    • New therapeutic agents, including B-cell targeting drugs, show promise for improved JSLE treatment.